How T lymphocytes switch between life and death

European Journal of Immunology

Volumn 36, Issue 7, 2006, Pages 1654-1658

  Arnold, Rüdiger ^a   Brenner, Dirk ^a   Becker, Mareike ^a   Frey, Christian R ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AICD; CD95; Lysosomes; Mitochondria; TCR

Indexed keywords

CASPASE; CATHEPSIN; CYTOKINE; DEATH RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEINASE; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; AUTOIMMUNE DISEASE; CELL DEATH; CELL FATE; CELL SURVIVAL; ENZYME ACTIVATION; IMMUNE DEFICIENCY; LYSOSOME; MEMORY T LYMPHOCYTE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; HUMANS; T-LYMPHOCYTES;

EID: 33746217907     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636197     Document Type: Short Survey

References (63)

1. Green, D. R., Droin, N. and Pinkoski, M., Activation-induced cell death in T cells. Immunol. Rev. 2003. 193: 70-81.
2. Krammer, P. H., CD95's deadly mission in the immune system. Nature 2000. 407: 789-795.
3. Hildeman, D. A., Zhu, Y. N., Mitchell, T. C., Kappler, J. and Marrack, P., Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 2002. 14: 354-359.
4. Krueger, A., Fas, S. C., Baumann, S. and Krammer, P. H., The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003. 193: 58-69.
5. Hildeman, D. A., Zhu, Y. N., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J. and Marrack, P., Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim. Immunity 2002. 16: 759-767.
6. Strasser, A. and Pellegrini, M., T-lymphocyte death during shutdown of an immune response. Trends Immunol. 2004. 25: 610-615.
7. Benczik, M. and Gaffen, S. L., The interleukin (IL)-2 family cytokines: Survival and proliferation signaling pathways in T lymphocytes. Immunol. Invest. 2004. 33: 109-142.
8. Schmitz, L., Krueger, A., Baumann, S., Schulze-Bergkamen, H., Krammer, P. H. and Kirchhoff, S., An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J. Immunol. 2003. 171: 2930-2936.
9. Kirchhoff, S., Muller, W. W., Krueger, A., Schmitz, I. and Krammer, P. H., TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 2000. 165: 6293-6300.
10. Brenner, D., Golks, A., Kiefer, F., Krammer, P. H. and Arnold, R., Activation or suppression of NF-κB by HPK1 determines sensitivity to activation-induced cell death. EMBO J. 2005. 24: 4279-4290.
11. Teague, T. K., Schaefer, B. C., Hildeman, D., Bender, J., Mitchell, T., Kappler, J. W. and Marrack, P., Activation-induced Inhibition of Interleukin 6-mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling. J. Exp. Med. 2000. 191: 915-926.
12. Refaeli, Y., Van Parijs, L., Alexander, S. I. and Abbas, A. K., Interferon [gamma] is required for activation-induced death of T lymphocytes. J. Exp. Med. 2002. 196: 999-1005.
13. Gulow, K., Kaminski, M., Darvas, K., Suss, D., Li-Weber, M. and Krammer, P. H., H1V-1 Trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J. Immunol. 2005. 174: 5249-5260.
14. Li-Weber, M. and Krammer, P. H., Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin. Immunol. 2003. 15: 145-157.
15. Lavrik, I., Golks, A. and Krammer, P. H., Death receptor signaling. J. Cell Sci. 2005. 118: 265-267.
16. Golks, A., Brenner, D., Fritsch, C., Krammer, P. H. and Lavrik, I. N., c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis. J. Biol. Chem. 2005. 280: 14507-14513.
17. Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H. and Kirchhoff, S., Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 2001. 276: 20633-20640.
18. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H. and Peter, M. E., Two CD95 (APO-1/ Fas) signaling pathways. EMBO J. 1998. 17: 1675-1687.
19. Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H. and Peter, M. E., Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 1999. 274: 22532-22538.
20. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 1994. 76: 969-976.
21. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
22. Hao, Z., Hampel, B., Yagita, H. and Rajewsky, K., T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J. Exp. Med. 2004. 199: 1355-1365.
23. Kroemer, G., Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ. 1997. 4: 443-456.
24. Hill, M. M., Adrain, C. and Martin, S. J., Portrait of a killer: The mitochondrial apoptosome emerges from the shadows. Mol. Interv. 2003. 3: 19-26.
25. Lavrik, I. N., Golks, A. and Krammer, P. H., Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 2005. 115: 2665-2672.
26. Zhu, Y., Swanson, B. J., Wang, M., Hildeman, D. A., Schaefer, B. C., Liu, X., Suzuki, H. et al., Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 7681-7686.
27. Sandalova, E., Wei, C. H., Masucci, M. G. and Levitsky, V., Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc. Natl. Acad. Sci. USA 2004. 101: 3011-3016.
28. 2+ signals according to the strength of T cell receptor activation. J. Cell Biol. 2006. 172: 127-137.
29. 2+-dependent transcriptional induction of Bim. J. Immunol. 2006. 176: 2299-2306.
30. Strasser, A., The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 2005. 5: 189-200.
31. Karin, M. and Lin, A., NF-κB at the crossroads of life and death. Nat. Immunol. 2002. 3: 221-227.
32. Ruland, J. and Mak, T. W., From antigen to activation: specific signal transduction pathways linking antigen receptors to NF-κB. Semin. Immunol. 2003. 15: 177-183.
33. Siebenlist, U., Brown, K. and Claudio, E., Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 2005. 5: 435-445.
34. Mittal, A., Papa, S., Franzoso, G. and Sen, R., NF-κB-dependent regulation of the timing of activation-induced cell death of T lymphocytes. J. Immunol. 2006. 176: 2183-2189.
35. Kane, L. P., Lin, J. and Weiss, A., It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol. 2002. 23: 413-420.
36. Schmitz, M. L., Bacher, S. and Dienz, O., NF-κB activation pathways induced by T cell costimulation. FASEB J. 2003. 17: 2187-2193.
37. Kerstan, A. and Hunig, T., Cutting edge: Distinct TCR- and CD28-derived signals regulate CD95L, Bcl-x(L), and the survival of primary T cells. J. Immunol. 2004. 172: 1341-1345.
38. Kirchhoff, S., Muller, W. W., Li-Weber, M. and Krammer, P. H., Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 2000. 30: 2765-2774.
39. Noel, P. J., Boise, L. H., Green, J. M. and Thompson, C. B., CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 1996. 157: 636-42.
40. Budd, R. C., Yeh, W. C. and Tschopp, J., cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 2006. 6: 196-204.
41. Golks, A., Brenner, D., Krammer, P. H. and Lavrik, I. N., The c-FLIP NH2 terminus (p22-FLIP) induces NF-κB activation. J. Exp. Med. 2006. 203: 1295-1305.
42. Kamata, H., Honda, S., Maeda, S., Chang, L. F., Hirata, H. and Karin, M., Reactive oxygen species promote TNF alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005. 120: 649-661.
43. Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S. et al., Ferritin heavy chain upregulation by NF-κB inhibits TNF alpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004. 119: 529-542.
44. Hildeman, D. A., Mitchell, T., Aronow, B., Wojciechowski, S., Kappler, J. and Marrack, P., Control of Bcl-2 expression by reactive oxygen species. Proc. Natl. Acad. Sci. USA 2003. 100: 15035-15040.
45. Shishodia, S. and Aggarwal, B. B., Guggulsterone inhibits NF-κB and IκBα kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem. 2004. 279: 47148-47158.
46. Campbell, K. J., Rocha, S. and Perkins, N. D., Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB. Mol. Cell 2004. 13: 853-865.
47. Wan, Y. S. Y. and DeGregori, J., The survival of antigen-stimulated T cells requires NF-κB-mediated inhibition of p73 expression. Immunity 2003. 18: 331-342.
48. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. and Dowdy, S. F., A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 2000. 407: 642-645.
49. Bommhardt, U., Beyer, M., Hünig, T. and Reichardt, H. M., Molecular and cellular mechanisms of T Cell development. Cell. Mol. Life Sci. 2004. 61: 263-280.
50. Arnold, R., Liou, J., Drexler, H. C. A., Weiss, A. and Kiefer, F., Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFκB into an inhibitor of NFκB. J. Biol. Chem. 2001. 276: 14675-14684.
51. Misra, R. S., Jelley-Gibbs, D. M., Russell, J. Q., Huston, G., Swain, S. L. and Budd, R. C., Effector CD4(+) T cells generate intermediate caspase activity and cleavage of caspase-8 substrates. J. Immunol. 2005. 174: 3999-4009.
52. Salmena, L., Lemmers, B., Hakem, A., Matysiak-Zablocki, E., Murakami, K., Au, P. Y. B., Berry, D. M. et al., Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 2003. 17: 883-895.
53. Su, H., Bidere, N., Zheng, L. X., Cubre, A., Sakai, K., Dale, J., Salmena, L. et al., Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 2005. 307: 1465-1468.
54. Los, M., Stroh, C., Janicke, R. U., Engels, I. H. and Schulze-Osthoff, K., Caspases: more than just killers? Trends Immunol. 2001. 22: 31-34.
55. Siegel, R. M., Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 2006. 6: 308-317.
56. Salvesen, G. S. and Duckett, C. S., IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell. Biol. 2002. 3: 401-410.
57. Kroemer, G. and Jaattela, M., Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 2005. 5: 886-897.
58. Bidere, N., Lorenzo, H. K., Carmona, S., Laforge, M., Harper, F., Dumont, C. and Senik, A., Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 2003. 278: 31401-31411.
59. Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J. L., Metivier, D., Ojcius, D. M. et al., Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 2003. 197: 1323-1334.
60. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O. and Kimchi, A., Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNFα. EMBO J. 1996. 15: 3861-3870.
61. Wang, D., Muller, N., McPherson, K. G. and Reichardt, H. M., Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J. Immunol. 2006. 176: 1695-1702.
62. Turk, V., Turk, B. and Turk, D., Lysosomal cysteine proteases: facts and opportunities. EMBO J. 2001. 20: 4629-4633.
63. Kondo, Y., Kanzawa, T., Sawaya, R. and Kondo, S., The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005. 5: 726-734.